From the operational update:
Novartis intends to initiate a Phase 3 study in non-COVID-19-related ARDS after the anticipated
closing of the license agreement and successful completion and outcome of the current study.
MSB Trading 2020 - a new dawn, page-10445
-
- There are more pages in this discussion • 2,626 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
92.0¢ |
Change
-0.005(0.54%) |
Mkt cap ! $1.050B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 92.5¢ | 91.5¢ | $526.3K | 572.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1020 | 92.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 92.5¢ | 118883 | 37 |
View Market Depth
| Last trade - 12.28pm 18/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |